Format

Send to

Choose Destination
Nat Rev Immunol. 2007 Aug;7(8):650-4. doi: 10.1038/nri2137.

What does the future hold for cell-based tolerogenic therapy?

Author information

1
Immune Tolerance Network and of the Diabetes Center at the University of California, USA.

Abstract

Evidence from animal models has shown that the transfer of regulatory T cells or tolerogenic dendritic cells can prevent or cure transplant rejection or re-establish self-tolerance in autoimmune disease. The potential of these tolerogenic cells for the treatment of T-cell-mediated diseases in humans has gained momentum in recent years. Here, Nature Reviews Immunology asks four leading researchers to provide their view on the future of cell-based tolerogenic therapy and to highlight some important issues that must be considered before this form of immunotherapy can become a reality.

PMID:
17653127
DOI:
10.1038/nri2137
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center